Keywords: ibex, neutralase, heparin, neutralization, technologies, canada, completed

IBEX' Neutralase For Heparin Neutralization

Article | 13 November 1995

Print This

IBEX Technologies of Canada has completed its second Phase Ib trial of Neutralase (heparinase I), its lead product for the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in